We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$98.4B
AUM Growth
+$12.2B
Cap. Flow
+$4.67B
Cap. Flow %
4.75%
Top 10 Hldgs %
7.81%
Holding
4,101
New
656
Increased
1,629
Reduced
1,101
Closed
596

Sector Composition

Rank Sector Weight
1 Technology 13.24%
2 Financials 10.53%
3 Industrials 10.31%
4 Healthcare 10.01%
5 Consumer Discretionary 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLJP icon
2926
Franklin FTSE Japan ETF
FLJP
$3.92B
$184K ﹤0.01%
+5,732
New +$175K
FDIS icon
2927
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.61B
$184K ﹤0.01%
1,954
-269
-12% -$23.7K
EWT icon
2928
iShares MSCI Taiwan ETF
EWT
$9.9B
$181K ﹤0.01%
+3,152
New +$161K
OKTA icon
2929
PUT
Okta
OKTA
$24.2B
$180K ﹤0.01%
1,800
-3,400
-65% -$363K
VB icon
2930
Vanguard Small-Cap ETF
VB
$79.6B
$180K ﹤0.01%
759
-1,743
-70% -$389K
LYB icon
2931
PUT
LyondellBasell Industries
LYB
$18.9B
$179K ﹤0.01%
+3,100
New +$181K
IQDG icon
2932
WisdomTree International Quality Dividend Growth Fund
IQDG
$700M
$178K ﹤0.01%
+4,485
New +$168K
SSP icon
2933
E.W. Scripps
SSP
$277M
$178K ﹤0.01%
60,376
-60,098
-50% -$145K
EEX
2934
DELISTED
Emerald Holding
EEX
$176K ﹤0.01%
36,336
+82
+0.2% +$357
PLRX icon
2935
Pliant Therapeutics
PLRX
$66.9M
$176K ﹤0.01%
+151,662
New +$214K
CRVS icon
2936
Corvus Pharmaceuticals
CRVS
$1.12B
$176K ﹤0.01%
43,969
-405,111
-90% -$1.47M
NATR icon
2937
Nature's Sunshine
NATR
$367M
$176K ﹤0.01%
11,872
-18,239
-61% -$246K
PXF icon
2938
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
$173K ﹤0.01%
3,015
+2,651
+728% +$144K
IUSB icon
2939
iShares Core Universal USD Bond ETF
IUSB
$43B
$167K ﹤0.01%
+3,609
New +$165K
BBCA icon
2940
JPMorgan BetaBuilders Canada ETF
BBCA
$10.8B
$166K ﹤0.01%
+2,061
New +$156K
VFC icon
2941
CALL
VF Corp
VFC
$6.71B
$166K ﹤0.01%
+14,100
New +$175K
HBNC icon
2942
Horizon Bancorp
HBNC
$1.04B
$166K ﹤0.01%
10,771
-4,504
-29% -$66.2K
BDTX icon
2943
Black Diamond Therapeutics
BDTX
$101M
$165K ﹤0.01%
66,451
+40,703
+158% +$78.4K
AI icon
2944
CALL
C3.ai
AI
$1.36B
$165K ﹤0.01%
+6,700
New +$153K
SWK icon
2945
PUT
Stanley Black & Decker
SWK
$14.4B
$163K ﹤0.01%
+2,400
New +$155K
RTAC
2946
Renatus Tactical Acquisition Corp I
RTAC
$327M
$161K ﹤0.01%
+13,652
New +$157K
CWEB icon
2947
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$228M
$161K ﹤0.01%
+4,056
New +$152K
ESGU icon
2948
iShares ESG Aware MSCI USA ETF
ESGU
$17.7B
$161K ﹤0.01%
1,187
-3,715
-76% -$464K
WM icon
2949
PUT
Waste Management
WM
$96.3B
$160K ﹤0.01%
+700
New +$162K
IUSV icon
2950
iShares Core S&P US Value ETF
IUSV
$27.2B
$160K ﹤0.01%
1,687
-1,316
-44% -$119K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2025 Portfolio in Review

As of Q2 2025, Qube Research & Technologies (QRT) held 4,101 positions worth $98.4B, up 14% from $86.2B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.67B of net new capital in Q2 2025, opening 656 new positions and adding to 1,629 existing holdings. Its largest new stake was Bristol-Myers Squibb: 9,752,683 shares worth $451M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $675M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2025 buy was Bristol-Myers Squibb: 9,752,683 shares worth $451M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2025, an estimated $486M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $675M.
  • Qube Research & Technologies (QRT) fully exited Broadcom in Q2 2025, selling an estimated $1.02B.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.8% of its $98.4B portfolio in Q2 2025.
  • Qube Research & Technologies (QRT) opened 656 new positions and closed 596 in Q2 2025.
  • Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $98.4B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.